Bayer AG is on a winning streak as it battles the remaining cases targeting its Roundup weedkiller, a change after multiple jurors held it to be cancer-causing and the company set aside nearly $16 billion for settlements. were kept.
Bayer AG is on a winning streak as it battles the remaining cases targeting its Roundup weedkiller, a change after multiple jurors held it to be cancer-causing and the company set aside nearly $16 billion for settlements. were kept.